Anti-CD19 UCAR-T cells
PBC081
Phase 1 small_molecule active
Quick answer
Anti-CD19 UCAR-T cells for Dermatomyositis, Juvenile is a Phase 1 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Dermatomyositis, Juvenile
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active